Short Interest in Agape ATP Corporation (NASDAQ:ATPC) Expands By 5,924.2%

Agape ATP Corporation (NASDAQ:ATPC) was the target of a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 314,161 shares, an increase of 5,924.2% from the May 14th total of 5,215 shares. Approximately 32.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 12,517,087 shares, the days-to-cover ratio is currently 0.0 days.

Agape ATP Stock Performance

Agape ATP stock traded up $0.07 during trading on Tuesday, reaching $3.12. The company had a trading volume of 1,513,020 shares, compared to its average volume of 2,429,269. The firm’s 50-day simple moving average is $2.82 and its 200 day simple moving average is $9.83. Agape ATP has a 1-year low of $1.72 and a 1-year high of $85.50. The firm has a market capitalization of $3.12 million, a PE ratio of -2.35 and a beta of 0.05.

Agape ATP (NASDAQ:ATPC) last issued its quarterly earnings results on Friday, May 15th. The company reported ($0.33) earnings per share (EPS) for the quarter. Agape ATP had a negative return on equity of 8.43% and a negative net margin of 125.89%.The firm had revenue of $0.27 million during the quarter.

Institutional Investors Weigh In On Agape ATP

A hedge fund recently raised its stake in Agape ATP stock. Citadel Advisors LLC grew its holdings in Agape ATP Corporation (NASDAQ:ATPC) by 95.7% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 65,130 shares of the company’s stock after buying an additional 31,849 shares during the period. Citadel Advisors LLC owned 0.13% of Agape ATP worth $82,000 as of its most recent filing with the Securities & Exchange Commission. 0.01% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on ATPC shares. Wall Street Zen raised shares of Agape ATP from a “sell” rating to a “hold” rating in a research note on Sunday, April 12th. Weiss Ratings reissued a “sell (e+)” rating on shares of Agape ATP in a research note on Friday, May 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Agape ATP Company Profile

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement.